Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1B/2 Study of PAC-1 and Entrectinib for Patients With Metastatic Uveal Melanoma

NCT04589832 is registered in ClinicalTrials.gov with Arkadiusz Z. Dudek, MD as lead sponsor.

NCT NCT04589832
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04589832 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1B/2 Study of PAC-1 and Entrectinib for Patients With Metastatic Uveal Melanoma
Lead sponsor
Arkadiusz Z. Dudek, MD
Phase
Phase 1/2
Overall status
Terminated
Start date
January 11, 2021
Completion date
June 24, 2022
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

uveal melanoma